The DOI matches its Crossref record; 154 of the 154 references it cites were found in a registry or an index.
Prostanoid Receptors: Subtypes and Signaling
Abstract
Cyclooxygenases metabolize arachidonate to five primary prostanoids: PGE 2, PGF 2α, PGI 2, TxA 2, and PGD 2. These autacrine lipid mediators interact with specific members of a family of distinct G-protein-coupled prostanoid receptors, designated EP, FP, IP, TP, and DP, respectively. Each of these receptors has been cloned, expressed, and characterized. This family of eight prostanoid receptor complementary DNAs encodes seven transmembrane proteins which are typical of G-protein-coupled receptors and these receptors are distinguished by their ligand-binding profiles and the signal transduction pathways activated on ligand binding. Ligand-binding selectivity of these receptors is determined by both the transmembrane sequences and amino acid residues in the putative extracellular-loop regions. The selectivity of interaction between the receptors and G proteins appears to be mediated at least in part by the C-terminal tail region. Each of the EP 1, EP 3, FP, and TP receptors has alternative splice variants described that alter the coding sequence in the C-terminal intracellular tail region. The C-terminal variants modulate signal transduction, phosphorylation, and desensitization of these receptors, as well as altering agonist-independent constitutive activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGE2 activates the protein kinase A (PKA) signaling pathway via raising the intracellular levels of cyclic adenosine 3′,5′-monophosphate (cAMP)12–14, which can enhance the binding of steroidogenic factor-1 (SF-1) to promoters of these steroidogenic genes15, and induce phosphorylation of the transcriptional activator cAMP-response element-binding protein (CREB)16.”
From Platelets induce increased estrogen production through NF-κB and TGF-β1 signaling pathways in endometriotic stromal cells (2020) · cites this paper as [14]
Citations
Cites
Moncada, S., Gryglewski, R. J., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,593
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,417
Coleman, R. A., Smith, W. L., & Narumiya, S. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06784-5 · Cited by 1,747
Ji, T. H., Grossmann, M., & Ji, I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.28.17299 · Cited by 1,281
G-protein-coupled receptor heterodimerization modulates receptor function
Jordan, B. A., & Devi, L. A. (1999) · Nature · doi:10.1038/21441 · Cited by 1,169
The probable arrangement of the helices in G protein‐coupled receptors.
Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968
Tuder, R. M., Cool, C. D., Geraci, M. W., Wang, J., Abman, S. H., Wright, L. A., Badesch, D. B., & Voelkel, N. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.6.9804054 · Cited by 804
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Cloning and expression of cDNA for a human thromboxane A2 receptor
Hirata, M., Hayashi, Y., Ushikubi, F., Yokota, Y., Kageyama, R., Nakanishi, S., & Narumiya, S. (1991) · Nature · doi:10.1038/349617a0 · Cited by 679
Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677
Research works printed but not linked: 18
- Coleman RA, 1994, Pharmacol. Rev., 46, 205
- Leach AR. 1996.Molecular Modelling. Essex, England: Longman Ltd.pp. 25–90
- Kolakowski L, 1994, Mol. Pharmacol. Recept. Channels, 2, 1
- Morinelli TA, 1989, J. Pharmacol. Exp. Ther., 251, 557
- Kinsella BT, 1997, J. Pharmacol. Exp. Ther., 281, 957
- Funk CD, 1993, Mol. Pharmacol., 44, 934
- Sakamoto K, 1994, J. Biol. Chem., 5, 3381
- Fujino H, 2000, Mol. Pharmacol., 57, 353
- Coleman RA, Kennedy I, Humphrey PPA, Bunce K, Lumley P. 1990.Prostanoids and their receptors.InComprehensive Medicinal Chemistry, ed. JC Emmet, pp. 643–714. Oxford, UK: Pergamon
- Abramovitz M, 1995, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 499
- Regan JW, 1994, Mol. Pharmacol., 46, 213
- Guan Y, 1996, J. Am. Soc. Nephrol, 7, 1646
- Nishigaki N, 1996, Mol. Pharmacol., 50, 1031
- Perkins W, 1991, J. Pharmacol. Exp. Ther., 259, 1004
- 10.1042/0264-6021:3400365 · DOI
- Audoly L, 1999, J. Pharmacol. Exp. Ther., 289, 140
- Edwards RM, 1985, Am. J. Physiol., 248, F779
- Kotani M, 1995, Mol. Pharmacol., 48, 869
Cited by
Sorted by citations
Items 501–600 of 1,000
Gq-Dependent Signaling Upregulates COX2 in Glomerular Podocytes
Wang, L., Flannery, P. J., Rosenberg, P. B., Fields, T. A., & Spurney, R. F. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010113 · Cited by 25
PGE2 inhibits spermatogonia differentiation in zebrafish: interaction with Fsh and an androgen
Crespo, D., Lemos, M. S., Zhang, Y., Safian, D., Norberg, B., Bogerd, J., & Schulz, R. W. (2019) · Journal of Endocrinology · doi:10.1530/joe-19-0309 · Cited by 25
Complex and Controversial Roles of Eicosanoids in Fungal Pathogenesis
Ruiz, S., Zamith‐Miranda, D., Takács, T., Gácser, A., Nosanchuk, J. D., & Guimaraes, A. J. (2021) · Journal of Fungi · doi:10.3390/jof7040254 · Cited by 25
Markosyan, N., Dozier, B. L., Lattanzio, F. A., & Duffy, D. M. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.106.053769 · Cited by 25
Taniguchi, H., Anacker, C., Suarez-Mier, G. B., Wang, Q., & Andreasson, K. I. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.09.005 · Cited by 25
Molecular Pathways Linking Oxylipins to Nociception in Rats
Domenichiello, A. F., Sapio, M. R., Loydpierson, A. J., Maric, D., Goto, T., Horowitz, M. S., Keyes, G. S., Yuan, Z., Majchrzak‐Hong, S. F., Mannes, A. J., et al. (2020) · Journal of Pain · doi:10.1016/j.jpain.2020.09.001 · Cited by 24
Cyclic AMP‐mediated chloride secretion is induced by prostaglandin F2αin human isolated colon
Collins, D., Hogan, A. M., Mm, S., Baird, A. W., & Winter, D. C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00464.x · Cited by 24
Bozza, W. P., Zhang, Y., Hallett, K., Rosado, L. A. R., & Zhang, B. (2015) · Oncotarget · doi:10.18632/oncotarget.5416 · Cited by 24
Pascoe, M. C., Crewther, S. G., Carey, L. M., & Crewther, D. P. (2011) · Clinical Nutrition · doi:10.1016/j.clnu.2011.03.013 · Cited by 24
MicroRNA and AU-rich element regulation of prostaglandin synthesis
Moore, A. E., Young, L. E., & Dixon, D. A. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9300-5 · Cited by 24
Endogenous bioactive lipids and the regulation of conventional outflow facility
Wan, Z., Woodward, D. F., & Stamer, W. D. (2008) · Expert Review of Ophthalmology · doi:10.1586/17469899.3.4.457 · Cited by 24
Vasko, M. R., Malty, R. H., Guo, C., Duarte, D. B., Zhang, Y. H., & Nicol, G. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104529 · Cited by 24
Nakanishi, M., Sato, T., Li, Y., Nelson, A. J., Farid, M., Michalski, J., Kanaji, N., Wang, X., Basma, H., Patil, A., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0115oc · Cited by 24
Cyclooxygenase 2 Promotes Parathyroid Hyperplasia in ESRD
Zhang, Q., Qiu, J., Li, H., Lu, Y., Wang, X., Yang, J., Wang, S., Zhang, L., Gu, Y., Hao, C., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060594 · Cited by 24
Role of EP2and EP4receptors in airway microvascular leak induced by prostaglandin E2
Jones, V. C., Birrell, M. A., Maher, S. A., Griffiths, M., Grace, M. S., O’Donnell, V. B., Clark, S., & Belvisi, M. G. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13400 · Cited by 24
Wise, H. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.02.018 · Cited by 26
Bundey, R. A., & Insel, P. A. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028035 · Cited by 24
Neuschäfer‐Rube, F., Engemaier, E., Koch, S., Böer, U., & Püschel, G. P. (2003) · Biochemical Journal · doi:10.1042/bj20021429 · Cited by 24
Jewell, M. L., BREYER, R. M., & Currie, K. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.068569 · Cited by 24
Self-citationMakita, H., Mutoh, M., Maruyama, T., Yonemoto, K., Kobayashi, A., Fujitsuka, H., Toida, M., Shibata, T., Miyamoto, S., Yasui, Y., et al. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl178 · Cited by 24
Haddad, A., Flint-Ashtamker, G., Minzel, W., Sood, R., Rimon, G., & Barki‐Harrington, L. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304220 · Cited by 23
The distribution of the prostaglandin E receptor type 2 (EP2) in the detrusor of the guinea pig
Rahnama’i, M. S., Biallosterski, B. T., Wachter, S. D., Kerrebroeck, P. V., & van Koeveringe, G. A. (2012) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2012.08.005 · Cited by 23
Chun, K., & Langenbach, R. J. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20728 · Cited by 23
Aslan, J. E. (2017) · Springer eBooks · doi:10.1007/978-3-319-47462-5_24 · Cited by 23
Risk management profile of etoricoxib: an example of personalized medicine
Patrignani, P. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3209 · Cited by 23
Mori, A., Saito, M., Sakamoto, K., Nakahara, T., & Ishii, K. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0061061 · Cited by 23
Chiba, T., Kanda, A., Ueki, S., Ito, W., Kamada, Y., Oyamada, H., Saito, N., Kayaba, H., & Chihara, J. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000095436 · Cited by 23
Takadera, T., & Ohyashiki, T. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.02.014 · Cited by 23
Sabichi, A. L., Subbarayan, V., Llansa, N., Lippman, S. M., & Menter, D. G. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.1704.13.11 · Cited by 23
Montalban, E., Giralt, A., Taing, L., Schut, E. H. S., Supiot, L. F., Castell, L., Nakamura, Y., de Pins, B., Pelosi, A., Goutebroze, L., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01439-4 · Cited by 24
Skibicka, K. P., Alhadeff, A. L., Leichner, T. M., & Grill, H. J. (2011) · Endocrinology · doi:10.1210/en.2010-1309 · Cited by 22
Khan, K. M. F., Kothari, P., Du, B., Dannenberg, A. J., & Falcone, D. J. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1102383 · Cited by 22
Identification of Drugs that Regulate Dermal Stem Cells and Enhance Skin Repair
Naska, S., Yuzwa, S. A., Johnston, A. P. W., Paul, S., Smith, K. M., Paris, M., Sefton, M. V., Datti, A., Miller, F. D., & Kaplan, D. R. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.12.002 · Cited by 22
The prostaglandin transporter (PGT) as a potential mediator of ovulation
Yerushalmi, G., Markman, S., Yung, Y., Maman, E., Aviel‐Ronen, S., Orvieto, R., Adashi, E. Y., & Hourvitz, A. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad2709 · Cited by 22
Lian, S., Xia, Y., Ung, T. T., Khoi, P. N., Yoon, H. J., Lee, S. G., Kim, K. K., & Jung, Y. D. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22524 · Cited by 22
Eguchi, M., Kariya, S., Okano, M., Higaki, T., Makihara, S., Fujiwara, T., Nagata, K., Hirai, H., Narumiya, S., Nakamura, M., et al. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04292.x · Cited by 22
Rice, K. M., Uddemarri, S., Desai, D. H., Morrison, R. G., Harris, R. T., Wright, G. L., & Blough, E. R. (2007) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2007.10.009 · Cited by 24
Cesare, A. D., Piccolo, P. D., Zacchetti, D., & Grohovaz, F. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6262-9 · Cited by 22
Bystanders or not? Microglia and lymphocytes in aging and stroke
Chauhan, A., & Nguyen, J. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.360345 · Cited by 21
Differential expression of E‐prostanoid receptors in human hepatocellular carcinoma
Breinig, M., Rieker, R. J., Eiteneuer, E. M., Wertenbruch, T., Haugg, A. M., Helmke, B. M., Schirmacher, P., & Kern, M. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23098 · Cited by 21
Ichikawa, Y., Yokoyama, U., Iwamoto, M., Oshikawa, J., Okumura, S., Sato, M., Yokota, S., Masuda, M., Asou, T., & Ishikawa, Y. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0215 · Cited by 21
Chae, I. G., Kim, D.-H., Kundu, J. K., Jeong, C., Kundu, J. K., & Chun, K. (2014) · Free Radical Research · doi:10.3109/10715762.2014.951838 · Cited by 21
Regulatory roles of PGE2 in LPS-induced tissue damage in bovine endometrial explants
Deng, Y., Liu, B., Mao, W., Shen, Y., Fu, C., Gao, L., Zhang, S., Wu, J., Li, Q., Li, T., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.044 · Cited by 22
Vahidinia, Z., Joghataei, M. T., Beyer, C., Karimian, M., & Tameh, A. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02435-5 · Cited by 22
Myeloid-Derived Suppressor Cells Dampen Airway Inflammation Through Prostaglandin E2 Receptor 4
van Geffen, C., Deißler, A., Beer‐Hammer, S., Nürnberg, B., Handgretinger, R., Renz, H. E., Hartl, D., & Kolahian, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.695933 · Cited by 21
Mosher, A. A., Rainey, K. J., Giembycz, M. A., Wood, S. L., & Slater, D. M. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.100099 · Cited by 21
Schlemper, V., Medeiros, R., Ferreira, J., Campos, M. M., & Calixto, J. Β. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706222 · Cited by 21
Bertin, J. O., Barat, C., Méthot, S., & Tremblay, M. J. (2012) · Retrovirology · doi:10.1186/1742-4690-9-4 · Cited by 21
Osborne, N. N., Li, G., Ji, D., da Costa, B. L. A., Fawcett, R. J., Kang, K. D., & Rittenhouse, K. D. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-3185 · Cited by 21
Clarke, D. L., Belvisi, M. G., Hardaker, E. L., Newton, R. C., & Giembycz, M. A. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.006486 · Cited by 21
Nakae, K., Saito, K., Iino, T., Yamamoto, N., Wakabayashi, M., Yoshikawa, S., Matsushima, S., Miyashita, H., Sugimoto, H., Kiba, A., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.091967 · Cited by 21
SCHERMULY, R. T., Schulz, A., Ghofrani, H. A., Breitenbach, S. C., Weißmann, N., Hildebrand, M. S., Kurz, J., Grimminger, F., & Seeger, W. (2006) · Journal of Aerosol Medicine · doi:10.1089/jam.2006.19.353 · Cited by 21
Discovery of novel biaryl heterocyclic EP1 receptor antagonists
Hall, A., Bit, R. A., Brown, S. H., Chaignot, H. M., Chessell, I. P., Coleman, T., Giblin, G. M. P., Hurst, D. N., Kilford, I. R., Lewell, X. Q., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.02.014 · Cited by 21
SC-19220, Antagonist of Prostaglandin E2 Receptor EP1, Inhibits Osteoclastogenesis by RANKL
Tsujisawa, T., Inoue, H., & Nishihara, T. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041011 · Cited by 23
Discovery of novel aminothiadiazole amides as selective EP3 receptor antagonists
Hilfiker, M. A., Wang, N., Hou, X., Du, Z., Pullen, M. A., Nord, M., Nagilla, R., Fries, H. E., Wu, C. W., Sulpizio, A. C., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.074 · Cited by 20
The Cell Biology of Vasopressin Action
Brown, D., & Fenton, R. A. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6193-9.10011-9 · Cited by 20
Role of the COX2-PGE2 axis in S. pneumoniae-induced exacerbation of experimental fibrosis
Bormann, T., Maus, R., Stolper, J., Jonigk, D. D., Welte, T., Gauldie, J., Kolb, M. R. J., & Maus, U. A. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00024.2020 · Cited by 20
Abayalath, N., Malshani, I., Ariyaratne, R., Zhao, S., Zhong, G., Zhang, G., Manipura, A., SIRIBADDANA, A. A., Karunaratne, P., & Kodithuwakku, S. P. (2021) · Chemosphere · doi:10.1016/j.chemosphere.2021.131741 · Cited by 20
Lipid Signalling in the Pathology of Autism Spectrum Disorders
Wong, C. T., & Crawford, D. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-4788-7_68 · Cited by 24
Sex hormone effects in non-pregnant rat and human myometrium
Vedernikov, Y. P., Hartke, J. R., de Long, M. A., Saade, G. R., & Garfield, R. E. (2003) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/s0301-2115(02)00415-3 · Cited by 20
Identification and optimization of novel 1,3,4-oxadiazole EP1 receptor antagonists
Hall, A., Brown, S. H., Chowdhury, A., Giblin, G. M. P., Gibson, M., Healy, M. P., Livermore, D. G., Wilson, R. J. M., Naylor, A., Rawlings, D. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.06.014 · Cited by 20
Phosphatidylinositol transfer protein α regulates growth and apoptosis of NIH3T3 cells
Schenning, M., van Tiel, C. M., van Manen, D., Stam, J. C., Gadella, B. M., WIRTZ, K. W. A., & Snoek, G. T. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400127-jlr200 · Cited by 20
Lv, X., Gao, K., Nie, J., Zhang, X., Zhang, S., Ren, Y., Sun, X., Li, Q., Huang, J., Liu, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43922-8 · Cited by 19
Abera, A. B., Sales, K. J., Catalano, R. D., Katz, A. A., & Jabbour, H. N. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.09.012 · Cited by 19
Evans, D. H., Harrie, A. C., & Kozlowski, M. S. (2003) · Journal of Experimental Zoology Part A Comparative Experimental Biology · doi:10.1002/jez.a.10238 · Cited by 19
Burelout, C., Naccache, P. H., & Bourgoin, S. G. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0406256 · Cited by 19
Analgesic and anti‐inflammatory properties of novel, selective, and potent EP4 receptor antagonists
Chandrasekhar, S., Yu, X., Harvey, A. K., Oskins, J. L., Lin, C., Wang, X.-S., Blanco, M.-J., Fisher, M. J., Kuklish, S. L., Schiffler, M. A., et al. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.316 · Cited by 19
Genetic and molecular biology of bladder cancer among Iranian patients
Mojarrad, M., & Moghbeli, M. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1233 · Cited by 19
A short guide to the nomenclature of seven-transmembrane spanning receptors for lipid mediators
Howlett, A. C. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.003 · Cited by 19
Bone Biomechanical Properties in EP4 Knockout Mice
Akhter, M. P., Cullen, D. M., & Pan, L. C. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0186-5 · Cited by 19
Ozkurt, I. C., Pirih, F. Q. M., & Tetradis, S. (2004) · Endocrinology · doi:10.1210/en.2003-1436 · Cited by 19
Krishnan, A. V., Srinivas, S., & Feldman, D. (2009) · Dermato-Endocrinology · doi:10.4161/derm.1.1.7106 · Cited by 19
Possible cross‐regulation of the E prostanoid receptors
Tober, K. L., Thomas‐Ahner, J. M., Maruyama, T., & Oberyszyn, T. M. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20347 · Cited by 19
Zhang, M., Feigenson, M., Sheu, T., Awad, H. A., Schwarz, E. M., Jonason, J. H., Loiselle, A. E., & O’Keefe, R. J. (2014) · Bone · doi:10.1016/j.bone.2014.11.018 · Cited by 19
Rebamipide retards CCl4-induced hepatic fibrosis in rats: Possible role for PGE2
Zakaria, S., & El‐Sisi, A. E. (2016) · Journal of Immunotoxicology · doi:10.3109/1547691x.2015.1128022 · Cited by 19
Xu, J., Xu, Z., & Yan, A. (2017) · Neurochemical Research · doi:10.1007/s11064-016-2168-6 · Cited by 19
Kwok, A. H. Y., Wang, Y., Wang, C. Y., & Leung, F. C.-C. (2008) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2008.04.001 · Cited by 19
Misoprostol elevates intracellular calcium in Neuro-2a cells via protein kinase A
Tamiji, J., & Crawford, D. A. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.07.112 · Cited by 19
Liu, K., Zhen, W., Bai, D., Tan, H., He, X., Li, Y., Liu, Y., Zhang, Y., Ito, K., Zhang, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1193798 · Cited by 18
Pantazaka, E., Taylor, E. J. A., Bernard, W. G., & Taylor, C. W. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12239 · Cited by 18
Kim, S., Lewis, C. C., & Nadel, J. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.023 · Cited by 18
Airway relaxation mechanisms and structural basis of osthole for improving lung function in asthma
Wang, S., Xie, Y., Huo, Y., Li, Y., Abel, P. W., Jiang, H., Zou, X., Jiao, H.-Z., Kuang, X., Wolff, D. W., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aax0273 · Cited by 18
Surh, I., Rundhaug, J. E., Pavone, A., Mikulec, C. D., Abel, E. L., Simper, M., & Fischer, S. M. (2011) · Molecular Carcinogenesis · doi:10.1002/mc.20820 · Cited by 18
Harizi, H. (2015) · Mediators of Inflammation · doi:10.1155/2015/841097 · Cited by 18
Prostaglandin E2EP3 receptor regulates cyclooxygenase-2 expression in the kidney
Vio, C. P., Quiroz‐Munoz, M., Cuevas, C. A., Céspedes, C., & Ferreri, N. R. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00634.2011 · Cited by 18
The effects of bimatoprost and unoprostone isopropyl on the intraocular pressure of normal cats
Bartoe, J. T., Davidson, H. J., Horton, M. T., Jung, Y., & Brightman, A. H. (2005) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2005.00397.x · Cited by 18
Miyake, J. A., Gomes, R. N., & Colquhoun, A. (2020) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2020.106452 · Cited by 18
Alvarez-Soria, M. A., Largo, R., Sánchez‐Pernaute, O., Calvo, E., Egido, J., & Herrero‐Beaumont, G. (2007) · Rheumatology International · doi:10.1007/s00296-007-0328-3 · Cited by 18
Lipid Mediators of Hypersensitivity and Inflammation
Peebles, R. S., & Boyce, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00010-3 · Cited by 18
Holmgaard, K., Aalkjær, C., Lambert, J. D. C., & Bek, T. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1890 · Cited by 17
Roles of the prostaglandin E2 receptors EP subtypes in Alzheimer’s disease
Wei, L., Shen, Y., Zhang, Y., Hu, X., Lu, P.-L., Wang, L., & Chen, W. (2010) · Neuroscience Bulletin · doi:10.1007/s12264-010-0703-z · Cited by 17
Effect of mesenchymal stem cell in liver regeneration and clinical applications
Lee, S. M., Lee, S. D., Wang, S. Z., Sarkar, D., Lee, H. M., Khan, A. A., Bhati, C. S., Sharma, A., Kumaran, V., Bruno, D. A., et al. (2021) · Hepatoma Research · doi:10.20517/2394-5079.2021.07 · Cited by 17
Increased severity of renal impairment in nephritic mice lacking the EP1 receptor
Rahal, S. S., McVeigh, L. I., Zhang, Y., Guan, Y., Breyer, M. D., & Kennedy, C. (2006) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-029 · Cited by 17
Self-citationFujimori, K., Ueno, T., & Amano, F. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2010.06.005 · Cited by 17
Shin, V. Y., Jin, H., Ng, E. K. O., Cho, C. H., Leung, W. K., Sung, J. J. �., & Chu, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01885.x · Cited by 17
Fuchikami, C., Murakami, K., Tajima, K., Homan, J., Kosugi, K., Kuramoto, K., Oka, M., & Kuwano, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.11.057 · Cited by 17
Fan, F., Tian, H., Geng, J., Deng, J., Liu, Y., Chen, C., Zhang, S., Zhang, Y., Li, J., Tian, H., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01518 · Cited by 17
Prostaglandin Biosynthesis and Action in the Ovary
Sirois, J., Boerboom, D., & Sayasith, K. (2004) · Elsevier eBooks · doi:10.1016/b978-012444562-8/50014-8 · Cited by 17
Perchick, G. B., & Jabbour, H. N. (2003) · Endocrinology · doi:10.1210/en.2003-0986 · Cited by 17
Particulate Air Pollution and Blood Pressure: Signaling by the Arachidonate Metabolism
Wang, T., Han, Y., Chen, X., Chen, W., Li, H., Wang, Y., Qiu, X., Gong, J., Li, W., & Zhu, T. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21410 · Cited by 16
Metadata
- Authors
- Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D.
- Affiliations
- United States Department of Veterans Affairs (US)
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2001-04
- Volume
- 41
- Issue
- 1
- Pages
- 661-690
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2129746956
- Cited by
- 1,011
- References
- 152
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 11 · 2023: 22 · 2022: 17 · 2021: 27 · 2020: 37 · 2019: 22 · 2018: 24 · 2017: 32 · 2016: 38 · 2015: 43 · 2014: 50 · 2013: 40 · 2012: 51
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM 15431)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK37097, DK46205, R01DK037097, R01DK046205)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Eicosanoids and Hypertension Pharmacology
- Keywords
- prostanoid receptors, G protein-coupled receptors, prostaglandins, cyclooxygenase, arachidonic acid metabolism, prostaglandin E2, prostaglandin F2alpha, prostacyclin, thromboxane A2, prostaglandin D2, receptor subtypes, ligand selectivity, splice variants, receptor desensitization, receptor phosphorylation, constitutive receptor activity, signal transduction
- MeSH terms
- Amino Acid Sequence, Animals, Humans, Molecular Sequence Data, Prostaglandins, Receptors, Prostaglandin, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review